XML 124 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2013
Segment Reporting [Abstract]  
Segment reporting information by segment
(in Millions)
Three Months Ended June 30
 
Six Months Ended June 30
2013
 
2012
 
2013
 
2012
Revenue
 
 
 
 
 
 
 
FMC Agricultural Solutions
$
442.6

 
$
393.6

 
$
937.8

 
$
847.8

FMC Health and Nutrition
189.9

 
174.4

 
381.8

 
339.0

FMC Minerals
244.4

 
249.5

 
469.0

 
485.7

FMC Peroxygens
83.6

 
87.8

 
163.2

 
173.7

Eliminations
(1.1
)
 
(0.1
)
 
(2.2
)
 
(0.3
)
Total
$
959.4

 
$
905.2

 
$
1,949.6

 
$
1,845.9

Income from continuing operations before income taxes
 
 
 
 
 
 
 
FMC Agricultural Solutions
$
124.7

 
$
112.3

 
$
288.0

 
$
242.8

FMC Health and Nutrition
44.3

 
44.9

 
88.0

 
85.7

FMC Minerals
35.4

 
44.9

 
64.4

 
92.5

FMC Peroxygens
4.0

 
7.8

 
9.7

 
14.7

Eliminations
(0.1
)
 
0.1

 
(0.2
)
 
0.1

Segment operating profit
208.3

 
210.0

 
449.9

 
435.8

Corporate and other
(20.3
)
 
(16.9
)
 
(40.1
)
 
(40.4
)
Operating profit before the items listed below
188.0

 
193.1

 
409.8

 
395.4

Restructuring and other (charges) income (1)
(6.5
)
 
(5.6
)
 
(16.4
)
 
(7.3
)
Interest expense, net
(12.3
)
 
(11.5
)
 
(24.0
)
 
(22.8
)
Non-operating pension and postretirement (charges) income (2)
(11.6
)
 
(9.1
)
 
(24.3
)
 
(18.2
)
Acquisition/divestiture related charges (3)
(1.6
)
 
(3.2
)
 
(1.6
)
 
(6.6
)
Provision for income taxes
(36.7
)
 
(45.3
)
 
(84.0
)
 
(90.1
)
Discontinued operations, net of income taxes
1.9

 
(8.1
)
 
(3.3
)
 
(15.5
)
Net income attributable to noncontrolling interests
$
(3.2
)
 
$
(5.4
)
 
$
(7.3
)
 
$
(10.9
)
Net income attributable to FMC stockholders
$
118.0

 
$
104.9

 
$
248.9

 
$
224.0

_________________________________________
(1)
See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended June 30, 2013, relate to FMC Agricultural Solutions of $1.4 million, FMC Health and Nutrition of $0.1 million, FMC Minerals of $3.5 million, FMC Peroxygens of $0.5 million and Corporate of $1.0 million. Amounts for the three months ended June 30, 2012, relate to FMC Agricultural Solutions of $1.3 million, FMC Health and Nutrition of $0.1 million, FMC Peroxygens of $2.8 million and Corporate of $1.4 million. Amounts for the six months ended June 30, 2013, related to FMC Agricultural Solutions of $2.0 million, FMC Health and Nutrition of $0.7 million, FMC Minerals of $9.3 million, FMC Peroxygens of $1.1 million and Corporate of $3.3 million. Amounts for the six months ended June 30, 2012, related to FMC Agricultural Solutions of $1.7 million, FMC Health and Nutrition of $0.2 million, FMC Minerals of $(0.3) million, FMC Peroxygens of $3.7 million and Corporate $2.0 million.
(2)
Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.
(3)
Charges related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting for acquisitions and costs incurred associated with the potential divestiture of our FMC Peroxygens segment. Charges for the three and six months ended June 30, 2013, represented legal and professional fees directly associated with the potential divestiture of our FMC Peroxygens segment. The charges for three and six month period ended June 30, 2012 relate to a number of acquisitions completed in 2011 and in the second quarter of 2012. On the condensed consolidated statements of income, the charges associated with inventory fair value step-up are included in “Costs of sales and services” and charges associated with the potential divestiture of FMC Peroxygens are included in "Selling, general and administrative expenses".